New York, NY (PRWEB) June 20, 2013
Actos lawsuit claims involving bladder cancer allegations continue to move forward in the multidistrict litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to court documents, a Status Conference was held in the Actos bladder cancer litigation on June 20th, at which time the Court received an update on the status of discovery and bellwether trials. The Court also scheduled the litigation’s next Status Conference for July 25th, 2013. (In re: Actos Product Liability Litigation, MDL No. 2299)
“Our Firm continues to hear from patients who may have developed bladder cancer due to long term use of this medication. We are pleased to see Actos lawsuits are progressing, and look forward to the first federal trial next year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to patients who developed bladder cancer after using the medication for an extended period of time.
Actos Bladder Cancer Lawsuits
Court documents indicate that more than 1,500 Actos lawsuits have been filed in the Western District of Louisiana. Bloomberg.com reported on May 1st that hundreds of similar claims have also been filed in state courts in California and Illinois. All of the pending lawsuits allege that long-term use of Actos, a type 2 diabetes drug manufactured by Takeda Pharmaceuticals, may cause or worsen bladder cancer. Plaintiffs further allege that Takeda failed to provide adequate warnings to doctors and patients regarding the drug’s association with an increased risk of bladder cancer.*
According to court records, the first trial in the federal Actos litigation is scheduled to begin on January 27, 2014. In April, the nation’s first trial involving Actos bladder cancer allegations ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking Actos for four years. However, the judge overseeing the case granted Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Actos lawsuits have been mounting in state and federal courts since June 2011, when the U.S. Food & Drug Administration warned that use of Actos for one year or more had been linked to the development of bladder cancer.** According to Bloomberg.com, Actos was also pulled from the market in Germany and France that month because of its association with bladder cancer.***
Alleged victims of Actos bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing an Actos lawsuit by visiting Bernstein Liebhard LLP’s website. For additional information, please contact Bernstein Liebhard LLP today by calling 800-511-5092.
*bloomberg.com/news/2013-05-01/takeda-gets-6-5-million-diabetes-drug-verdict-thrown-out.html, Bloomberg, May 1, 2013
**fda.gov/drugs/drugsafety/ucm259150.htm, FDA, June 15, 2011
***bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html, Bloomberg, March 5, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-bladder-cancer/prweb10855836.htm.
Copyright©2012 Vocus, Inc.
All rights reserved